Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma
Hematological Oncology · 2024
DOI: 10.1002/hon.3305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematological Oncology, 2024. Verfasst von Yan Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China. Hauptthemen laut MEDLINE: Lymphoma, Mantle-Cell, Zinc Finger Protein GLI1, Hedgehog Proteins, Wnt Signaling Pathway. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Mantle cell lymphoma (MCL) is a rare and aggressive form of non‐Hodgkin lymphoma. Challenges in its treatment include relapse, drug resistance, and a short survival period. The Hedgehog/GLI1 (Hh/GLI1) and Wnt/β‐catenin pathways are crucial in cancer cell proliferation, survival, and drug resistance, making them significant targets for anticancer research. This study aimed to assess the effectiveness of combining inhibitors for both pathways against MCL and investigate the underlying molecular mechanisms. The co‐expression of key proteins from the Hh/GLI1 and Wnt/β‐catenin pathways was observed in MCL. Targeting the Hh/GLI1 pathway with the GLI1 inhibitor GANT61 and the Wnt/β‐catenin pathway with the CBP/β‐catenin transcription inhibitor ICG‐001, dual‐target therapy was demonstrated to synergistically suppressed the activity of MCL cells. This approach promoted MCL cell apoptosis, induced G0/G1 phase blockade, decreased the percentage of S‐phase cells, and enhanced the sensitivity of MCL cells to the drugs adriamycin and ibrutinib. Both GANT61 and ICG‐001 downregulated GLI1 and β‐catenin while upregulating GSK‐3β expression. The interaction between Hh/GLI1 and Wnt/β‐catenin pathways was mediated by GANT61‐dependent Hh/GLI1 inhibition. Moreover, GLI1 knockdown combined with ICG‐001 synergistically induced apoptosis and increased drug sensitivity of MCL cells to doxorubicin and ibrutinib. GANT61 attenuated the overexpression of β‐catenin and decreased the inhibition of GSK‐3β in MCL cells. Overall, the combined targeting of both the Hh/GLI1 and Wnt/β‐catenin pathways was more effective in suppressing proliferation, inducing G0/G1 cycle retardation, promoting apoptosis, and increasing drug sensitivity of MCL cells than mono treatments. These findings emphasize the potential of combinatorial therapy for treating MCL patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
- Fujian Medical University, Fuzhou, China.
- Department of Blood Transfusion, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
ORCID-Profile: Yan Han
Förderung
- Natural Science Foundation of Fujian Province
Zitieren
APA
Han, Y., Li, C., Liu, S., Gao, J., He, Y., Xiao, H., Chen, Q., Zheng, Y., Chen, H., & Zhu, X. (2024). Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma. Hematological Oncology. https://doi.org/10.1002/hon.3305
Vancouver
Han Y, Li C, Liu S, Gao J, He Y, Xiao H, et al. Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma. Hematological Oncology. 2024. doi:10.1002/hon.3305
BibTeX
@article{Han2024,
author = {Han, Yan and Li, Chuntuan and Liu, Shengquan and Gao, Jingjing and He, Yanjun and Xiao, Huifang and Chen, Qi and Zheng, Yan and Chen, Hongyuan and Zhu, Xiongpeng},
title = {Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma},
journal = {Hematological Oncology},
year = {2024},
doi = {10.1002/hon.3305}
}
EUVIMED